PFSA NorthView Acquisition Corp

OTC N/A


$ 0.31 $ 0.00 (0.49 %)    

Wednesday, 15-Oct-2025 17:52:52 EDT
QQQ $ 603.56 $ 4.22 (0.71 %)
DIA $ 462.77 $ 0.00 (0 %)
SPY $ 665.96 $ 2.94 (0.44 %)
TLT $ 90.71 $ -0.20 (-0.22 %)
GLD $ 387.02 $ 6.60 (1.73 %)
$ 0.3089
$ 0.32
$ 0.31 x 3,000
$ 0.33 x 6,500
$ 0.30 - $ 0.40
$ 0.27 - $ 12.76
8,315,843
na
nm
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 06-13-2025 03-31-2025 10-Q
3 03-29-2025 12-31-2024 10-K
4 12-17-2024 09-30-2024 10-Q
5 11-15-2024 06-30-2024 10-Q
6 10-09-2024 03-31-2024 10-Q
7 02-23-2024 12-31-2023 10-K
8 11-20-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-17-2023 03-31-2023 10-Q
11 03-06-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-17-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

BERKELEY, Calif, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a ...

Core News & Articles

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001859807/000121390025097860/ea0258580-s1_profusa.htm

Core News & Articles

Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a commercial stage digital health company pioneering ...

Core News & Articles

Company expects early 2026 rollout in EEA; physician portal combines Lumee™ oxygen monitoring with NVIDIA NeMo to deliver AI-dr...

Core News & Articles

Led by Prof. Dr. Marianne Brodmann, PI of clinical studies for the Lumee™ Oxygen CE Mark, collaboration includes practice adopt...

Core News & Articles

Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a commercial stage digital health company pioneering ...

Core News & Articles

On July 28, 2025, Profusa, Inc. (the "Company") entered into a Securities Purchase Agreement (the "Purchase Agreeme...

Core News & Articles

Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a commercial stage digital health company pioneering ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION